ASO Author Reflections: De-escalation of Breast Cancer Surgery—A Leap Forward

Author:

Özkurt Enver,Golshan Mehra

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Reference5 articles.

1. van la Parra RF, Kuerer HM. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials. Breast Cancer Res. 2016;18(1):28.

2. Özkurt E, Sakai S, Wong SM, Tukenmez M, Golshan M. Survival Outcomes in patients with clinical complete response following neoadjuvant chemotherapy: is omitting surgery an option? Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07534-1 .

3. Mamounas EP. Omitting surgery in complete responders after neoadjuvant chemotherapy: the quest continues. Ann Surg Oncol. 2018;25(11):3119–22.

4. Assessing the accuracy of tumor biopsies after chemotherapy to determine if patients can avoid breast surgery: www.clinicaltrials.gov . https://clinicaltrials.gov/ct2/show/NCT03188393 .

5. Eliminating surgery after systemic therapy in treating patients with her2 positive or triple-negative breast cancer: www.clinicaltrials.gov . https://clinicaltrials.gov/ct2/show/NCT02945579 .

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3